Publications

2006

A. Jabbour, Smoum, R. , Takrouri, K. , Shalom, E. , Zaks, B. , Steinberg, D. , Rubinstein, A. , Goldberg, I. , Katzhendler, J. , and Srebnik, M. . 2006. “Pharmacologically Active Boranes”. Pure And Applied Chemistry, 78, 7, Pp. 1425-1453.

2005

A. Rubinstein. 2005. “Colonic Drug Delivery”. Drug Discovery Today: Technologies, 2, 1, Pp. 33-37.

T.T. Jubeh, Antler, S. , Haupt, S. , Barenholz, Y. , and Rubinstein, A. . 2005. “Local Prevention Of Oxidative Stress In The Intestinal Epithelium Of The Rat By Adhesive Liposomes Of Superoxide Dismutase And Tempamine”. Molecular Pharmaceutics, 2, 1, Pp. 2-11.

R. Smoum, Rubinstein, A. , and Srebnik, M. . 2005. “Noncovalent Inhibition Of The Serine Proteases, ?-Chymotrypsin And Trypsin By Trifluoro(Organo)Borates”. Organic And Biomolecular Chemistry, 3, 5, Pp. 941-944.

A.-K. Azab, Srebnik, M. , Doviner, V. , and Rubinstein, A. . 2005. “Targeting Normal And Neoplastic Tissues In The Rat Jejunum And Colon With Boronated, Cationic Acrylamide Copolymers”. Journal Of Controlled Release, 106, 1-2, Pp. 14-25.

2004

A. David, Kope?ková, P. , Minko, T. , Rubinstein, A. , and Kope?ek, J.. 2004. “Design Of A Multivalent Galactoside Ligand For Selective Targeting Of Hpma Copolymer-Doxorubicin Conjugates To Human Colon Cancer Cells”. European Journal Of Cancer, 40, 1, Pp. 148-157.

T.T. Jubeh, Barenholz, Y. , and Rubinstein, A. . 2004. “Differential Adhesion Of Normal And Inflamed Rat Colonic Mucosa By Charged Liposomes”. Pharmaceutical Research, 21, 3, Pp. 447-453.

2003

R. Smoum, Rubinstein, A. , and Srebnik, M. . 2003. “Combined ¹H, ¹³C And ¹¹B Nmr And Mass Spectral Assignments Of Boronate Complexes Of D-(+)-Glucose, D-(+)-Mannose, Methyl-?-D-Glucopyranoside, Methyl-?-D-Galactopyranoside And Methyl-?-D-Mannopyranoside”. Magnetic Resonance In Chemistry, 41, 12, Pp. 1015-1020.

R. Smoum, Rubinstein, A. , and Srebnik, M. . 2003. “A Study Of The Effect On Nucleophilic Hydrolytic Activity Of Pancreatic Elastase, Trypsin, Chymotrypsin, And Leucine Aminopeptidase By Boronic Acids In The Presence Of Arabinogalactan: A Subsequent Study On The Hydrolytic Activity Of Chymotrypsin By Boron”. Bioorganic Chemistry, 31, 6, Pp. 464-474.

2002

S. Haupt and Rubinstein, A. . 2002. “The Colon As A Possible Target For Orally Administered Peptide And Protein Drugs”. Critical Reviews In Therapeutic Drug Carrier Systems, 19, 6, Pp. 499-551.

S. Haupt, Gil, E. , Tirosh, R. , Klinger, E. , Gad, A. , and Rubinstein, A. . 2002. “Regional Peptide Uptake Study In The Rat Intestinal Mucosa: Glatiramer Acetate As A Model Drug”. Pharmaceutical Research, 19, 6, Pp. 832-837.

A. David, Kopecková, P. , Kope?ek, J. , and Rubinstein, A.. 2002. “The Role Of Galactose, Lactose, And Galactose Valency In The Biorecognition Of N-(2-Hydroxypropyl)Methacrylamide Copolymers By Human Colon Adenocarcinoma Cells”. Pharmaceutical Research, 19, 8, Pp. 1114-1122.

2001

A. David, Kope?ková, P. , Rubinstein, A. , and Kope?ek, J.. 2001. “Enhanced Biorecognition And Internalization Of Hpma Copolymers Containing Multiple Or Multivalent Carbohydrate Side-Chains By Human Hepatocarcinoma Cells”. Bioconjugate Chemistry, 12, 6, Pp. 890-899.

M. Baluom, Friedman, M. , and Rubinstein, A. . 2001. “Improved Intestinal Absorption Of Sulpiride In Rats With Synchronized Oral Delivery Systems”. Journal Of Controlled Release, 70, 1-2, Pp. 139-147.

2000

S. Blau, Jubeh, T.T. , Haupt, S.M. , and Rubinstein, A. . 2000. “Drug Targeting By Surface Cationization”. Critical Reviews In Therapeutic Drug Carrier Systems, 17, 5, Pp. 425-465.

A. Rubinstein, Blau, S. , Bass, P. , and Kohen, R. . 2000. “The Effect Of Adhesive Antioxidant Enzymes On Experimental Colitis In The Rat”. Acs Symposium Series, 752, Pp. 78-89.

S. Blau, Kohen, R. , Bass, P. , and Rubinstein, A. . 2000. “The Effect Of Local Attachment Of Cationized Antioxidant Enzymes On Experimental Colitis In The Rat”. Pharmaceutical Research, 17, 9, Pp. 1077-1084.

M. Baluom, Friedman, M. , and Rubinstein, A. . 2000. “Erratum: The Importance Of Intestinal Residence Time Of Absorption Enhancer On Drug Absorption And Implication On Formulative Considerations (International Journal Of Pharmaceutics (1998) 176 (21-30) Pii: S0378517398002889)”. International Journal Of Pharmaceutics, 193, 2, Pp. 265-266.

A. Rubinstein. 2000. “Natural Polysaccharides As Targeting Tools Of Drugs To The Human Colon”. Drug Development Research, 50, 3-4, Pp. 435-439.

I. Gliko-Kabir, Yagen, B. , Penhasi, A. , and Rubinstein, A. . 2000. “Phosphated Crosslinked Guar For Colon-Specific Drug Delivery - I. Preparation And Physicochemical Characterization”. Journal Of Controlled Release, 63, 1-2, Pp. 121-127.

first
«
1
2
3
4
5
6
»
last